Sfoglia per RIVISTA
PROSTATE CANCER AND PROSTATIC DISEASES
Collezione ASL Asti

  

Items : 3

Safety profile of darolutamide versus placebo: a systematic review and meta-analysis. in Prostate cancer and prostatic diseases / Prostate Cancer Prostatic Dis. 2024 Sep;27(3):385-392. doi: 10.1038/s41391-023-00775-y. Epub 2023 De

2024
ASL Asti
AO Ordine Mauriziano

Di Maio M; Tucci M; Vogl UM; Buttigliero C; Tombal B; Cathomas R; Smith MR; Fizazi K; Treglia G; Turco F; Gillessen S;

Prognostic role of the duration of response to androgen deprivation therapy in patients with metastatic castration resistant prostate cancer treated with enzalutamide or abiraterone acetate. in Prostate cancer and prostatic diseases / Prostate Cancer Prostatic Dis. 2021 Sep;24(3):812-825. doi: 10.1038/s41391-021-00336-1. Epub 2021 Fe

2021
ASL Asti
ASL Vercelli
AO Ordine Mauriziano

Di Maio M; Scagliotti GV; Gallicchio M; Vignani F; Pisano C; Bungaro M; Samuelly A; Turco F; Tucci M; Di Stefano RF; Buttigliero C;

The prognostic value of pain in castration-sensitive prostate cancer. in Prostate cancer and prostatic diseases / Prostate Cancer Prostatic Dis. 2020 Dec;23(4):654-660. doi: 10.1038/s41391-020-0255-x. Epub 2020 Jul

2020
ASL Asti
ASL Vercelli

Milella M; Casadei C; Buttigliero C; Maines F; Pierantoni F; Bimbatti D; Mosillo C; Tucci M; De Giorgi U; Caffo O; Ciccarese C; Tortora G; Iacovelli R;